Vericel Corp SEC filings VCEL
Vericel Corp has 1,002 filings in SEC EDGAR's recent list, going back to Aug 7, 2013. Its latest annual report, Form ARS, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Mar 19, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Mar 20, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Mar 21, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Mar 23, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 23, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 24, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Feb 24, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 25, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Feb 26, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 5, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 13, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 14, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 25, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 13, 2014 | Dec 31, 2013 |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- VCEL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MI
- Headquarters
- Burlington, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 887359
- Former names
- AASTROM BIOSCIENCES INC (until Nov 14, 2014)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.